Equities

Lawfinance Ltd

Lawfinance Ltd

Actions
EnergyOil, Gas and Coal
  • Price (AUD)0.005
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-37.50%
  • Beta2.4313
Data delayed at least 20 minutes, as of Apr 20 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LawFinance Limited is an Australia-based provider of finance solutions for the legal industry in the United States. The Company, through its subsidiary, National Health Finance HoldCo, LLC (NHF), operates a medical lien funding business in the United States. NHF purchases medical liens generally related to the provision of medical services to individuals involved in motor vehicle accidents where the services are required due to an injury sustained in the accident and where those individuals were the not-at-fault party (except in Michigan, which is a not-at-fault state). NHF's funding solution enables medical providers to maintain liquidity and reduce the administrative burden by managing the medical claims through the litigation process. NHF's funding solution is also of benefit to the lawyers acting on behalf of the injured party as it ensures there is no gap in medical care and the claim can be maximized. Its subsidiaries include JustKapital STL Pty and JustKapital NHF USA Holdings.

  • Revenue in AUD (TTM)-28.71m
  • Net income in AUD-47.33m
  • Incorporated1999
  • Employees--
  • Location
    Lawfinance LtdSuite 335, 49-51 Queens Road, Five DockSYDNEY 2046AustraliaAUS
  • Phone+61 29696-0220
  • Fax+61 29252-3430
  • Websitehttps://www.lawfinance.com.au/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.